Primary Site >> Pancreatic Cancer
Gene >> MUC16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Clinical significance of serum CA125 values in patients with cancers of the digestive system. PMID: 3459357 |
Ref: [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (2) Comparison and combination of BFP with other tumor markers]. PMID: 2456040 Ref: Expression of CA125 in pancreatic carcinoma and chronic pancreatitis. PMID: 3207606 |
Ref: Partial purification and characterization of CA19-9 antigen from the ascitic fluid of a patient with pancreatic cancer. PMID: 2805338 |
Ref: Evaluation of TATI and other markers in solid tumors. PMID: 1780686 |
Ref: [Early detection of pancreatic cancer by serum markers]. PMID: 7511183 |
Ref: [Sensitivity and specificity of tumor markers in cancer diagnosis]. PMID: 8691613 Ref: Solid and papillary neoplasms of the pancreas. PMID: 8711936 |
Ref: Immunocytochemical analysis of cell lines derived from solid tumors. PMID: 11668190 |
Ref: An original administration of ifosfamide given once every other week: a clinical and pharmacological study. PMID: 18510176 |
Ref: The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays. PMID: 19377061 Ref: [A resected case of effective treatment with S-1/gemcitabine and Paclitaxel combination chemotherapy for advanced pancreatic cancer with peritoneal and liver metastases]. PMID: 19620816 Ref: Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells. PMID: 19714813 Ref: Identification of a biomarker panel using a multiplex proximity ligation assay improves accuracy of pancreatic cancer diagnosis. PMID: 20003342 Ref: Markedly elevated CA19-9 associated with benign ovarian cyst and ascites. PMID: 21686409 |
Ref: Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms. PMID: 20395854 |
Ref: A novel high-affinity human monoclonal antibody to mesothelin. PMID: 20635390 Ref: Pathobiological implications of MUC16 expression in pancreatic cancer. PMID: 22066010 Ref: Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers. PMID: 22220206 Ref: Differential gene expression analysis of peripheral blood mononuclear cells reveals novel test for early detection of pancreatic cancer. PMID: 22820136 |
Ref: Mucin 16 is a functional selectin ligand on pancreatic cancer cells. PMID: 22159147 Ref: Coexpression of MUC16 and mesothelin is related to the invasion process in pancreatic ductal adenocarcinoma. PMID: 22320398 Ref: Mucin-based targeted pancreatic cancer therapy. PMID: 22372499 Ref: Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-alpha and TSGF after cryosurgery in pancreatic cancer patients. PMID: 22456901 Ref: Tuberculous lymphadenopathy mimicking pancreatic neoplasm. PMID: 22851977 Ref: Intraductal tubular neoplasms of the bile ducts. PMID: 23073323 |
Ref: The role of mesothelin in tumor progression and targeted therapy. PMID: 22721387 Ref: Mesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation. PMID: 23694968 Ref: Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing. PMID: 24039759 Ref: CA125 is superior to CA19-9 in predicting the resectability of pancreatic cancer. PMID: 24146342 Ref: MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer. PMID: 24204560 |
Ref: Clinical value of serum tumor markers CA19-9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma. PMID: 24649344 Ref: Diagnosis of pancreatic carcinoma based on combined measurement of multiple serum tumor markers using artificial neural network analysis. PMID: 24824251 Ref: Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer. PMID: 25239611 |
Ref: Dilution effect of serum CA125 and CA19-9 over a cutoff value, according to obesity. PMID: 25262704 Ref: Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients. PMID: 25486903 Ref: Expression and diagnostic value of HE4 in pancreatic adenocarcinoma. PMID: 25642754 Ref: Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells. PMID: 25691062 Ref: MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism. PMID: 26046375 Ref: Distinct kinetic and mechanical properties govern mucin 16- and podocalyxin-mediated tumor cell adhesion to E- and L-selectin in shear flow. PMID: 26329844 |
Ref: The clinical utility of CA125/MUC16 in pancreatic cancer: A consensus of diagnostic, prognostic and predictive updates by the Chinese Study Group for Pancreatic Cancer (CSPAC). PMID: 26718269 Ref: DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells. PMID: 27230679 Ref: [A Case of Early-Onset Rapidly Progressive Cerebral Infarction with Trousseau's Syndrome in a Patient with Pancreatic Cancer Undergoing Surgery]. PMID: 28133197 |
Ref: Cancer Antigen 125 (CA125, MUC16) Protein Expression in the Diagnosis and Progression of Pancreatic Ductal Adenocarcinoma. PMID: 27093451 Ref: Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma. PMID: 28108627 Ref: Galectin-3 is a non-classic RNA binding protein that stabilizes the mucin MUC4 mRNA in the cytoplasm of cancer cells. PMID: 28262838 Ref: Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. PMID: 29132146 Ref: Amatuximab and novel agents targeting mesothelin for solid tumors. PMID: 29184420 |
Ref: Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass. PMID: 29171983 Ref: MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer. PMID: 29337110 Ref: Detection and proteomic characterization of extracellular vesicles in human pancreatic juice. PMID: 29550476 Ref: Fn3 proteins engineered to recognize tumor biomarker mesothelin internalize upon binding. PMID: 29738555 Ref: Multilayered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/betacatenin signaling activation (Review). PMID: 29786110 Ref: Clean Colorectum at Diagnostic Colonoscopy: Subsequent Detection of Extracolonic Malignancies by Plasma Protein Biomarkers? PMID: 29872358 Ref: MiR-29a, targeting caveolin 2 expression, is responsible for limitation of pancreatic cancer metastasis in patients with normal level of serum CA125. PMID: 29978477 Ref: [Diagnosis and treatment experience of 161 cases of pancreatic serous cystic neoplasm in single center and analysis of cause of preoperation misjudgement]. PMID: 30107701 Ref: Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas. PMID: 30236127 Ref: Protein Synthesis Inhibition Activity of Mesothelin Targeting Immunotoxin LMB-100 Decreases Concentrations of Oncogenic Signaling Molecules and Secreted Growth Factors. PMID: 30384408 |